A Phase I, Open Label, Two Period, Single Fixed-Sequence Crossover Study to Evaluate the Effect of Etravirine on GSK1349572 Pharmacokinetics in Healthy Adult Subjects (ING111603).
Phase of Trial: Phase I
Latest Information Update: 18 Dec 2008
At a glance
- Drugs Dolutegravir (Primary) ; Etravirine
- Indications HIV-1 infections
- Focus Pharmacokinetics
- Sponsors GlaxoSmithKline
- 18 Dec 2008 Actual end date (Dec 2008) added as reported by ClinicalTrials.gov.
- 18 Dec 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 11 Nov 2008 New trial record.